Documentation scienceplus.abes.fr version Bêta

À propos de : Selective serotonin reuptake inhibitors in obsessive-compulsive disorder        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Selective serotonin reuptake inhibitors in obsessive-compulsive disorder
has manifestation of work
Abstract
  • Since we reviewed the selective serotonin reuptake inhibitor (SSRI) antidepressants two years ago1 two of them, fluoxetine (Prozac - Dista) and fluvoxamine (Faverin - Duphar), have also been licensed for the treatment of patients with obsessive-compulsive disorder. How do these and the other SSRIs available in the UK - paroxetine (Seroxat - SmithKline Beecham) and sertraline (Lustral - Invicta/Pfizer) - compare with clomipramine, a standard drug treatment for this disorder?2,3
article type
publisher identifier
  • dtdt9506
Alternative Title
  • Selective serotonin reuptake inhibitors in obsessive-compulsive disorder
is part of this journal
PubMed ID
  • 7587998



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata